Vanguard Group Inc Ardelyx, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ARDX
# of Institutions
220Shares Held
141MCall Options Held
1.08MPut Options Held
2M-
Janus Henderson Group PLC London, X021.5MShares$106 Million0.08% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$86.4 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$59.7 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C38.95MShares$44 Million0.07% of portfolio
-
Eventide Asset Management, LLC Boston, MA7.41MShares$36.5 Million0.9% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $761M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...